Br J Cancer 2006, 94:1369–1374.PubMedCrossRef 10. selleck compound Harter P, Gnauert K, Hils R, et al.: Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer 2007, 17:1238–1244.PubMedCrossRef 11. Desteli GA, Gultekin M, Usubutun A, et al.: Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature. World J Surg Oncol Barasertib mouse 2010, 8:106.PubMedCrossRef 12. Nomura H, Tsuda H, Susumu N, et al.: Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer. Int J Gynecol Cancer 2010, 20:341–345.PubMedCrossRef 13. Morice P, Joulie F, Camatte S, et
al.: Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003, 197:198–205.PubMedCrossRef 14. Kanazawa K, Suzuki T, Tokashiki M: The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol
1998, 73:237–241.CrossRef 15. Magazzino F, Katsaros D, Ottaiano A, et al.: Surgical and medical ITF2357 cell line treatment of clear cell ovarian cancer: results from the multicenter Italian Trials in Ovarian Cancer (MITO) 9 retrospective study. Int J Gynecol Cancer 2011, 21:1063–1070.PubMedCrossRef 16. Takano M, Sugiyama T, Yaegashi N, et al.: Less impact of adjuvant chemotherapy PIK3C2G for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study. Int J Gynecol Cancer 2010, 20:1506–1510.PubMed 17. Chan JK, Munro EG, Cheung MK, et al.: Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 2007, 109:12–19.PubMedCrossRef 18. Suzuki S, Kajiyama H, Shibata K, et al.: Is there any association between
retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol 2008, 19:1284–1287.PubMedCrossRef 19. Higashi M, Kajiyama H, Shibata K, et al.: Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types. Gynecol Oncol 2011, 123:474–478.PubMedCrossRef 20. Timmers PJ, Zwinderman AH, Teodorovic I, et al.: Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial. Int J Gynecol Cancer 2009, 19:88–93.PubMedCrossRef 21. Hoskins WJ, Bundy BN, Thigpen JT, et al.: The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 1992, 47:159–166.PubMedCrossRef 22. Kennedy AW, Markman M, Biscotti CV, et al.: Survival probability in ovarian clear cell adenocarcinoma. Gynecol Oncol 1999, 74:108–114.PubMedCrossRef 23. Schilder JM, Thompson AM, DePriest PD, et al.